Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Travere Therapeutics appointed Bradley L. Campbell as President and Chief Executive Officer and board member effective December 1, 2026. Eric Dube will step down from those roles and become Executive Advisor and consultant.
Bradley L. Campbell appointed president and CEO of Travere Therapeutics, effective Dec. 1, 2026. Outgoing CEO Eric Dube to remain until that date and then serve as executive advisor through Feb. 15, 2027.